Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Loop Diuretics Market size was over USD 2.66 billion in 2024 and is anticipated to cross USD 6.26 billion by 2037, witnessing more than 6.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of loop diuretics is estimated at USD 2.81 billion.
The growth of the market can be attributed to the growing prevalence of hypertension across the world as a result of large number of incidences of high blood pressure. Moreover, changing lifestyles and eating habits are also causing lifestyle-related diseases and several other chronic disorders, which is another factor expected to drive market growth in the coming years. According to the United Nations organization, the total number of deaths due to chronic diseases are expected to rise up to70% by 2030. The global of the burden is calculated to increase up to 56%. The demand for the loop diuretic market is also anticipated to rise significantly in the near future owing to the advancements in technology, growing cases of renal diseases, and increasing geriatric population globally. Along with these, increase in patient population and absence of appropriate treatment are evaluated to act as opportunities for market growth.
Loop Diuretics Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Geriatric Population Worldwide
- Rising Prevalence of Chronic Diseases
Challenges
- Side-Effects Associated with the Use of Loop Diuretics Drugs
Loop Diuretics Market: Key Insights
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
6.8% |
Base Year Market Size (2023) |
USD 2.49 billion |
Forecast Year Market Size (2036) |
USD 5.86 billion |
Regional Scope |
|
Loop Diuretics Segmentation
The market is segmented based on indication into diabetes insipidus, edema, hypercalciuria, hypertension, and others, out of which, the hypertension segment is anticipated to grab the largest share by the end of 2029 on account of increasing occurrence of high blood pressure among the global population and rising number of people following a sedentary lifestyle. Furthermore, on the basis of route of administration, the oral segment in the global loop diuretics market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that oral administration of a medicine is one of the most convenient, and usually the safest and least expensive method as compared to other ways of drug administration.
Our in-depth analysis of the global market includes the following segments
By Indication |
|
By Drugs |
|
By Route of Administration
|
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportLoop Diuretics Industry - Regional Synopsis
APAC Market Statistics
Geographically, the loop diuretics market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is set to dominate majority revenue share by 2037, owing to increasing prevalence of chronic diseases due to pollution and growing geriatric population in the region.
North America Market Analysis
Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to detrimental lifestyle changes and presence of leading healthcare service providers in the region. Along with this, North America also leads in terms of research and development of advanced loop diuretics, which is also expected to contribute to the market growth in the region. As per the analysis of Centres for Disease Control and Prevention, the top ten health problems in America are heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza and pneumonia, kidney disease, and septicaemia.
Companies Dominating the Loop Diuretics Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co.
- Meda Manufacturing GmbH
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Cipla Ltd
- Endo International plc
- Hikma Pharmaceuticals Inc.
- Teva Pharmaceuticals Industries Ltd
- Novartis AG
In the News
- May 22, 2020: Roche acquired Stratos Genomics for the development of DNA based sequencing to use for diagnosis. The investment directly complements the development of company’s nanopore technology to provide end-to-end sequencing solution.
Author Credits: Radhika Pawar
- Report ID: 3137
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT